Clinicomycological Study and Efficacy of Antifungal treatment in patients of Dermatophytosis in Department of Dermatology, GMERS Medical College And General Hospital, Gotri , Vadodara.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- ClinicalAnd Statistical Cure in pruritus, erythema and scaling score
研究概览
简要总结
Superficialfungal infection due to dermatophytosis is one of the most common skininfections in the India.It is contagious. The dermatophytes are a group offungi that invade the superficial layer of epidermis and degrade thekeratinized tissues of skin, hair and nails in living animals including man,causing ring worm. (1)(2) But in rare cases they invade the deeper layer of thedermis and other organs. A dermatophyte infection results in increased skinproliferation, scaling, and epidermal thickening.
Dermatophytosisis the fungal infection of keratinized tissue. It is caused by three asexualgenera- Trichophyton, Epidermophyton, and Microsporum. Dermatophytes arefilamentous, keratinophilic, pathogenic fungi which are readily identified bymicroscopic examination of clinical specimen and can be cultured easily inlaboratory. Depending on their habitat, they can be categorized as geophilic,zoophilic and anthropophilic.Based upon the affected site, thesehave been classified clinically into tinea capitis (head), tinea facei (face),tinea barbae (beard), tinea corporis (body), tinea mannum (hand), tinea cruris(groin), tinea pedis (foot), and tinea unguium (nail).
Fluconazole,terbinafine, itraconazole are commonly used antifungal agent indermatophytosis. Resistance to these drugs is being seen increasingly when usedin conventional doses and duration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients of either sex Patients 18 years or above Patient is suffering from dermatophyte infection diagnosed clinically Patient is suffering from dermatophyte infection in body and genitals Patients with scaling present on lesion Ability to give oral informed consent.
排除标准
- •Patient has been treated with oral or topical antifungal agents in last 3 months Patient on steroid therapy Patient having H/o hypersensitivity to above mentioned drugs Pregnancy or lactating mother Patient having any abnormal CVS, Renal , Hepatic functions or uncontrolled Diabetes Mellitus or HIV Patient who can’t come for regular follow up.
结局指标
主要结局
ClinicalAnd Statistical Cure in pruritus, erythema and scaling score
时间窗: ClinicalAnd Statistical Cure in pruritus, erythema and scaling score | Improvement in Global Assessment scale | Mycological cure by studying KOH | Outcome will be assessed after 1 year at the end of study | Patient will be follwed up after 15 days
Improvement in Global Assessment scaleMycological cure by studying KOH
时间窗: ClinicalAnd Statistical Cure in pruritus, erythema and scaling score | Improvement in Global Assessment scale | Mycological cure by studying KOH | Outcome will be assessed after 1 year at the end of study | Patient will be follwed up after 15 days
次要结局
- Improvement in global assessment score and mycological cure in koh(improvement in global assessment score and mycological cure in koh)
